Mirae Asset Capital
MA
About
Mirae Asset Venture Investment is a leading global venture capital firm with a strong presence in Asia and North America. They focus on investing in innovative companies across a range of sectors, including technology, healthcare, and consumer goods, from early-stage to growth-stage.
Key facts
At-a-glance profile data
- Website
- miraeasset.com
- Type
- VC
- Headquarters
- Seoul, South Korea
- Funds raised
- $1.2B
- Portfolio companies
- 6
- Stages
- Series ASeries B
- Cheque size
- $50M to $320M
- Sector focus
- TechnologyHealthcareFintechAIBiotechnology
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 29 May 2026 | XCENA | Series B | $135M |
| 3 Sept 2025 | IQM Quantum | Series B | $320M |
| 6 Feb 2024 | Rebellions | Undisclosed round | $124M |
| 11 Jul 2023 | Crossbow Therapeutics | Series A | $80M |
| 23 Mar 2023 | KREAM | Series C | $168M |
| 1 Jul 2022 | IQM Quantum | Undisclosed round | $128M |
| 1 Feb 2021 | IQM Quantum | Undisclosed round | $34M |
| 1 Nov 2020 | IQM Quantum | Undisclosed round | $39M |
| 1 Jul 2019 | IQM Quantum | Undisclosed round | $11M |
| 30 Apr 2019 | Vividion Therapeutics | Series B | $82M |
Add first review
Frequently asked
What companies has Mirae Asset Capital invested in?
Mirae Asset Capital has invested in XCENA, IQM Quantum, Rebellions, Crossbow Therapeutics, KREAM and 1 more.